Margaret M Stewart / Shutterstock.com
The US Food and Drug Administration (FDA) last week approved nine applications for the first generic versions of Pfizer’s Lyrica (pregabalin).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Pfizer, US Food and Drug Administration, FDA, Lyrica, pregabalin, patent extension, market exclusivity, paediatric exclusivity, patent expiry, generics